Agilent Technologies operates through three primary business segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The company offers a comprehensive portfolio of solutions, including liquid and gas chromatography, mass spectrometry, genomics, and cell analysis tools. Its products and services are utilized by pharmaceutical, biotechnology, academic, clinical, and industrial customers across more than 110 countries. The Agilent CrossLab segment provides services and consumables that span the entire laboratory workflow, while its diagnostics division focuses on pathology solutions for cancer diagnostics and oligo-based therapeutics. Following the 2014 spin-off of its electronic measurement business into Keysight Technologies, Agilent has operated purely as a life sciences and diagnostics company.
